Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Mccormick Frank

SEC-identified person · CIK 1257809 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Bridgebio Pharma, Inc. BBIO Director · Chairman of Oncology filed 2019 - 2026
Helix Acquisition Corp. II HLXB Director filed 2025 - 2026
Olema Pharmaceuticals, Inc. OLMA Director filed 2020 - 2020
Chinook Therapeutics, INC. KDNY Director filed 2015 - 2018
Exelixis, INC. XEL Director filed 2006 - 2013

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.